Novo India slashes price on growth therapy product Norditropin FlexPro by upto 35 per cent

The Hindu Business Line - Oct 15, 2026

Novo said, the move was aimed at expanding access and affordability to essential therapies for people living with growth hormone deficiency and related conditions across India

Read full article
More News
Copyright © 2015 - 2026 The Financial Capital.

All Rights Reserved.

Subscribe Now!

About Us

The Financial Capital is your independent source for finance information and advice. We provide insights and offer advice from financial experts so you can make the best decisions.